OTC Markets OTCPK - Delayed Quote USD

Trust for Advised Portfolios - FRC Founders Index Fund (FNDRX)

12.81 +0.06 (+0.49%)
At close: November 11 at 8:00 PM EST
Loading Chart for FNDRX
DELL
  • Previous Close 12.75
  • YTD Return -32.44%
  • Expense Ratio 0.73%
  • Category Mid-Cap Growth
  • Last Cap Gain 14.00
  • Morningstar Rating --
  • Morningstar Risk Rating --
  • Sustainability Rating --
  • Net Assets 186.85k
  • Beta (5Y Monthly) --
  • Yield 0.12%
  • 5y Average Return --
  • Holdings Turnover 75.00%
  • Last Dividend 0.02
  • Inception Date Jul 28, 2020

The index is a rules based benchmark of equity securities issued by publicly traded companies in which the founder or founders are actively involved and remain a key influence in the companies' strategy. The fund normally invests at least 85% of its net assets plus borrowings for investment purposes in the securities of the index using a replication approach, which means that it normally will invest in all of the securities comprising the index in proportion to the weightings in the index.

First Republic

Fund Family

Mid-Cap Growth

Fund Category

186.85k

Net Assets

2020-07-28

Inception Date

Performance Overview: FNDRX

Trailing returns as of 10/31/2022. Category is Mid-Cap Growth.

YTD Return

FNDRX
32.44%
Category
10.80%
 

1-Year Return

FNDRX
37.08%
Category
48.17%
 

3-Year Return

FNDRX
0.00%
Category
21.26%
 

5-Year Return

FNDRX
0.00%
Category
20.18%
 

Holdings: FNDRX

Top 10 Holdings (3.25% of Total Assets)

SymbolCompany% Assets
STNG
Scorpio Tankers Inc. 0.38%
NKTX
Nkarta, Inc. 0.35%
ALLO
Allogene Therapeutics, Inc. 0.34%
TMDX
TransMedics Group, Inc. 0.33%
FOLD
Amicus Therapeutics, Inc. 0.32%
VUZI
Vuzix Corporation 0.32%
DCPH
Deciphera Pharmaceuticals, Inc. 0.31%
PLAB
Photronics, Inc. 0.31%
UTHR
United Therapeutics Corporation 0.30%
SGEN
SGEN 0.29%

Sector Weightings

SectorFNDRX
Healthcare   30.92%
Technology   24.86%
Real Estate   8.61%
Industrials   4.10%
Energy   2.22%
Utilities   0.22%

Recent News: FNDRX

Research Reports: FNDRX

Top Mutual Funds